Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease

J Pediatr Gastroenterol Nutr. 2004 Sep;39(3):302-3. doi: 10.1097/00005176-200409000-00018.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / therapy*
  • Humans
  • Infliximab
  • Infusions, Parenteral
  • Safety
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Infliximab